Abstract
A dose-response study comparing ursodeoxycholic and chenodeoxycholic acid was carried out in six men with asymptomatic radiolucent gallstones present in well-visualizing gallbladders. The study tested the effects of a low (averaging 6 mg/kg/day) or medium dose (averaging 11 mg/kg/day) of each bile acid on the cholesterol saturation of bile as well as on bile acid metabolism, as inferred from biliary and fecal bile acid composition. Ursodeoxycholic acid, at low or medium doses, induced bile desaturation in most patients, whereas chenodeoxycholic acid did not. Despite the greater desaturation efficacy of ursodeoxycholic acid, biliary bile acids became less enriched with the administered bile acid during ursodeoxycholic acid treatment than during chenodeoxycholic acid treatment. Both bile acids were nearly completely 7-dehydroxylated to lithocholic acid by colonic bacteria, but biliary lithocholic increased only slightly (and similarly) with each bile acid. Fecal bile acid composition suggested that administered ursodeoxycholic acid suppressed endogenous bile acid synthesis much less than chenodeoxycholic acid. The results indicate that ursodeoxycholic acid and chenodeoxycholic acid have similar but not identical effects on bile acid metabolism, but that for a given dose, ursodeoxycholic acid is a more potent desaturating agent than chenodeoxycholic acid. The results suggest that cholesterol gallstone dissolution with ursodeoxycholic acid should occur with a dose of 8–10 mg/kg in most nonobese patients.
Similar content being viewed by others
References
Makino I, Shinozaki K, Yoshino K, Nakagawa S: Dissolution of cholesterol gallstones by ursodeoxycholic acid. Jpn J Gastroenterol 72:690–702, 1975
Nakagawa S, Makino I, Ishizaki T, Dohi I: Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet 2:367–369, 1977
Kameda et al: Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. Gastroenterology 78:542–548, 1980
Maton PN, Murphy GM, Dowling RH: Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action. Lancet 2:1297–1301, 1977
Polli EE, Bianchi PA, Conte D, Sironi L: Treatment of radiolucent gallstones with CDCA or UDCA: A multicenter trial. Digestion (in press)
Dowling RH, Hofmann AF, Barbara L (eds): Workshop on Ursodeoxycholic Acid. Baltimore, University Park Press, 1979
Salen G, Colalillo A, Verga D, Bagan E, Tint GS, Shefer S: Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans. Gastroenterology 78:1412–1418, 1980
Stiehl A, Czygan P, Kommerell B, Weis H, Holtermuller K-H: Ursodeoxycholic acid versus chenodeoxycholic acid: Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones. Gastroenterology 75:1016–1020, 1978
Okumura M, Tanikawa K, Chuman Y, Koji T, Nakagawa S, Nakamura Y, Iino H, Yamasaki S, Hisatsugu T: Clinical studies on dissolution of gallstones using ursodeoxycholic acid. Gastroenterol Jpn 12:469–475, 1977
Bateson MC, Ross PE, Murison J, Saunders JHB, Bouchier IAD: Ursodeoxycholic acid therapy and biliary lipids—a dose response study. Gut 21:305–310, 1980
Thistle JL, Hofmann AF, Ott BJ, Stephens DH: Chenotherapy for gallstones. I. Efficacy and safety. JAMA 239:1138–1144, 1978
Thistle JL, Hofmann AF, Yu PYS, Ott B: Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: A dose response study. Am J Dig Dis 22:1–6, 1977
Hofmann AF, Poley JR: Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology 62:918–934, 1972
Danzinger RG, Hofmann AF, Schoenfield LJ, Thistle JL: Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis. J Clin Invest 52:2809–2821, 1973
Carey MC, Small DM: The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man. J Clin Invest 61:998–1026, 1978
Carey MC, Ko G: The importance of total lipid concentration in determining cholesterol solubility in bile and the development of critical tables for calculating ‘percent cholesterol saturation’ with a correction factor of ursodeoxycholate-rich bile.In Biological Effects of Bile Acids. G Paumgartner, A Stiehl, and W Gerok, eds. MTP Press Limited, Lancaster 1979, pp 299
Makino I, Nakagawa S: Changes in biliary lipid and biliary bile acid composition in patients after administration of ursodeoxycholic acid. J Lipid Res 19:723–728, 1978
Salvioli G, Salati R: Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones. Gut 20:698–704, 1979
Salen G, Fedorowski T, Colalillo A, Mosbach EH: Metabolism of ursodeoxycholic acid in man.In Bile Acid Metabolism in Health and Disease. G Paumgartner, A Stiehl (eds). Lancaster, MTP Press Ltd, 1977, pp 167–172
Salen G, Nicolau G, Shefer S, Mosbach EH: Hepatic cholesterol metabolism in patients with gallstones. Gastroenterology 69:676–684, 1975
Key PH, Bonorris GG, Marks JW, Chung A, Schoenfield LJ: Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid. J Lab Clin Med 95:816–826, 1980
Maton PN, Ellis HJ, Higgins MJP, Dowling RH: Hepatic HMGCoA reductase in human cholelithiasis: Effects of chenodeoxycholic and ursodeoxycholic acids. Eur J Clin Invest 10:325–332, 1980
Ahlberg J: Biliary lipid metabolism in hyperlipoproteinaemia and gallstone disease. Acta Chir Scand Suppl 492, 1979
Carulli N, Ponz De Leon M, Zironi F, Pinetti A, Smerieri A, Iori R, Loria P: Hepatic cholesterol and bile acid metabolism in subjects with gallstones: Comparative effects of short term feeding of chenodeoxycholic and ursodeoxycholic acid. J Lipid Res 21:35–43, 1980
Erickson SK, Cooper AD, Matsui SM, Gould RG: 7-Ketocholesterol. Its effects on hepatic cholesterogenesis and its hepatic metabolismin vivo andin vitro. J Biol Chem 252:5186–5193, 1977
Gilmore IT, Stokes K, Hofmann AF, Gurantz D, Lorenzo D: Differing acute effects of chenodeoxycholyl conjugates and ursodeoxycholyl conjugates on biliary phospholipid and cholesterol secretion in gallstone patients. Gastroenterology 79:1020, 1980 (abstract)
Sama C, Lopez V, LaRusso NF, Thistle JL: Acute administration of ursodeoxycholic acid decreases biliary cholesterol secretion in man. Gastroenterology 79:1052, 1980 (abstract)
Carey MC, Mazer NA, Benedek GB: Novel physicalchemical properties of ursodeoxycholic acid (UDCA) and its conjugates: Relevance to gallstone dissolution in man. Gastroenterology 72:1036, 1977 (abstract)
Hisadome T, Nakama T, Itoh H, Furusawa T: Physicalchemical properties of chenodeoxycholic acid and ursodeoxycholic acid. Gastroenterol Jpn 15:257, 1980
Corrigan OI, Su CC, Higuchi WI, Hofmann AF: Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: A new mechanism for gallstone dissolution in man. J Pharm Sci 69:869–871, 1980
Su CC, Alkan MH, Park JY, Corrigan OI, Higuchi WI, Hofmann AF, Danzinger RG:In vitro dissolution behavior of cholesterol monohydrate and cholesterol gallstones in ursodeoxycholate (UDCA)-lecithin media. J Pharm Sci (in press)
Roda E, Roda A, Sama C, Festi D, Mazzella G, Aldini R, Barbara L: Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients. Dig Dis Sci 24:123–128, 1979
Hoffman NE, Hofmann AF: Metabolism of steroid and amino acid moieties of conjugated bile acids in man. V. Equations for the perturbed enterophepatic circulation and their application. Gastroenterology 72:141–148, 1977
Fromm H, Farivar S, Hofmann AF, Carlson GL, Amin P: Metabolism in man of 7-ketolithocholic acid, a major secondary bile acid. Am J Phys 239:G161-G166, 1980
Author information
Authors and Affiliations
Additional information
Supported in part by NIH grants AM 15887, 16770, and 21506.
Rights and permissions
About this article
Cite this article
Thistle, J.L., Larusso, N.F., Hofmann, A.F. et al. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. Digest Dis Sci 27, 161–168 (1982). https://doi.org/10.1007/BF01311711
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01311711